Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAlembic

    Alembic

    Jump to
    • Alembic Consolidated September 2025 Net Sales at Rs 55.86 crore, up 5.57% Y-o-Y

      Alembic Consolidated September 2025 Net Sales at Rs 55.86 crore, up 5.57% Y-o-Y

    • Alembic Standalone September 2025 Net Sales at Rs 54.04 crore, up 5.76% Y-o-Y

      Alembic Standalone September 2025 Net Sales at Rs 54.04 crore, up 5.76% Y-o-Y

    • Alembic Standalone June 2025 Net Sales at Rs 47.89 crore, down 2.42% Y-o-Y

      Alembic Standalone June 2025 Net Sales at Rs 47.89 crore, down 2.42% Y-o-Y

    • Alembic Standalone March 2025 Net Sales at Rs 58.22 crore, up 22.54% Y-o-Y

      Alembic Standalone March 2025 Net Sales at Rs 58.22 crore, up 22.54% Y-o-Y

    • Alembic Consolidated March 2025 Net Sales at Rs 60.27 crore, up 22.9% Y-o-Y

      Alembic Consolidated March 2025 Net Sales at Rs 60.27 crore, up 22.9% Y-o-Y

    • Alembic Consolidated December 2024 Net Sales at Rs 57.92 crore, up 47.29% Y-o-Y

      Alembic Consolidated December 2024 Net Sales at Rs 57.92 crore, up 47.29% Y-o-Y

    • Alembic Standalone December 2024 Net Sales at Rs 55.97 crore, up 47.52% Y-o-Y

      Alembic Standalone December 2024 Net Sales at Rs 55.97 crore, up 47.52% Y-o-Y

    • Senores IPO: A B2B play in pharma generics

      Senores IPO: A B2B play in pharma generics

      Senores has an interesting business model, focusing on generic product identification and development. For the commercialisation and marketing of those products, it has tied up with large generic players.

    • Trade Spotlight: How should you trade HDFC AMC, Tata Communications, Lemon Tree Hotels, KRBL, PCBL, IRCTC, and others on Thursday?

      Trade Spotlight: How should you trade HDFC AMC, Tata Communications, Lemon Tree Hotels, KRBL, PCBL, IRCTC, and others on Thursday?

      The consolidation is likely to continue until the benchmark indices decisively break the tight range of the past four days on either side. Below are some trading ideas for the near term.

    • Alembic Standalone September 2024 Net Sales at Rs 51.10 crore, up 64.03% Y-o-Y

      Alembic Standalone September 2024 Net Sales at Rs 51.10 crore, up 64.03% Y-o-Y

    • Alembic Consolidated September 2024 Net Sales at Rs 52.91 crore, up 63.92% Y-o-Y

      Alembic Consolidated September 2024 Net Sales at Rs 52.91 crore, up 63.92% Y-o-Y

    • Alembic Consolidated June 2024 Net Sales at Rs 50.78 crore, up 37.84% Y-o-Y

      Alembic Consolidated June 2024 Net Sales at Rs 50.78 crore, up 37.84% Y-o-Y

    • Alembic Standalone June 2024 Net Sales at Rs 49.08 crore, up 37.68% Y-o-Y

      Alembic Standalone June 2024 Net Sales at Rs 49.08 crore, up 37.68% Y-o-Y

    • Alembic Standalone March 2024 Net Sales at Rs 47.51 crore, up 31.61% Y-o-Y

      Alembic Standalone March 2024 Net Sales at Rs 47.51 crore, up 31.61% Y-o-Y

    • Alembic Consolidated December 2023 Net Sales at Rs 39.33 crore, up 28.47% Y-o-Y

      Alembic Consolidated December 2023 Net Sales at Rs 39.33 crore, up 28.47% Y-o-Y

    • Alembic Standalone December 2023 Net Sales at Rs 37.94 crore, up 28.44% Y-o-Y

      Alembic Standalone December 2023 Net Sales at Rs 37.94 crore, up 28.44% Y-o-Y

    • Alembic Consolidated September 2023 Net Sales at Rs 32.28 crore, down 13.74% Y-o-Y

      Alembic Consolidated September 2023 Net Sales at Rs 32.28 crore, down 13.74% Y-o-Y

    • Alembic Standalone September 2023 Net Sales at Rs 31.15 crore, down 14.39% Y-o-Y

      Alembic Standalone September 2023 Net Sales at Rs 31.15 crore, down 14.39% Y-o-Y

    • Alembic Consolidated June 2023 Net Sales at Rs 36.84 crore, up 66.77% Y-o-Y

      Alembic Consolidated June 2023 Net Sales at Rs 36.84 crore, up 66.77% Y-o-Y

    • Alembic Standalone June 2023 Net Sales at Rs 35.65 crore, up 68.71% Y-o-Y

      Alembic Standalone June 2023 Net Sales at Rs 35.65 crore, up 68.71% Y-o-Y

    • Alembic Pharmaceuticals posts Rs 120.6 crore profit in Q1

      Alembic Pharmaceuticals posts Rs 120.6 crore profit in Q1

      The company’s India revenues grew 9 per cent to Rs 524 crore, while the US generics were up 6 per cent at Rs 390 crore in the quarter, the company said in the filing.

    • Alembic Standalone March 2023 Net Sales at Rs 36.10 crore, up 107.5% Y-o-Y

      Alembic Standalone March 2023 Net Sales at Rs 36.10 crore, up 107.5% Y-o-Y

    • Alembic Consolidated March 2023 Net Sales at Rs 37.12 crore, up 103.56% Y-o-Y

      Alembic Consolidated March 2023 Net Sales at Rs 37.12 crore, up 103.56% Y-o-Y

    • Alembic Standalone December 2022 Net Sales at Rs 29.54 crore, up 58.78% Y-o-Y

      Alembic Standalone December 2022 Net Sales at Rs 29.54 crore, up 58.78% Y-o-Y

    • Alembic Standalone December 2022 Net Sales at Rs 29.54 crore, up 58.78% Y-o-Y

      Alembic Standalone December 2022 Net Sales at Rs 29.54 crore, up 58.78% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347